34853628|t|Systemic Response of Antioxidants, Heat Shock Proteins, and Inflammatory Biomarkers to Short-Lasting Exercise Training in Healthy Male Subjects.
34853628|a|Regular physical activity can enhance immune function and effectively prevents the spread of the cytokine response, thus reducing systemic low-grade inflammation and improving various immune markers. Moreover, regular exercise maintains redox homeostasis in skeletal muscle and other tissues, including immune cells, but the interconnection between the anti-inflammatory effects of exercise with the redox status of immune cells is still poorly understood. With the aim to verify the overall beneficial effect of regular training on the immune system, we have examined the acute and short-term effect of a 5-day exercise program on the modulation of protein and lipid oxidation, antioxidants (i.e., superoxide dismutase-1 (SOD1) and superoxide dismutase-2 (SOD2), glutathione peroxide 1 (GPx1), thioredoxin reductase-1 (TrxR1), and catalase (CAT)), and heat shock protein expression (i.e., heat shock protein-70 (HSP70) and heat shock protein-27 (HSP27)), at both mRNA and protein levels, as well as the activation of the nuclear factor kappa light chain enhancer of activated B cells (NFkappaB) in peripheral blood mononuclear cells (PBMCs). Moreover, plasmatic markers of oxidative stress, inflammation, and stress response (i.e., protein carbonyl content, interleukin-6 (IL6), interleukin-8 (IL8), interleukin-10 (IL10), interleukin-17E (IL17E), interleukin-17F (IL17F), interleukin-21 (IL21), interleukin-22 (IL22), and interleukin-23 (IL23)) were analyzed in active untrained young adult subjects. Even in the absence of an increased amount of protein or lipid oxidation, we confirmed a PBMC upregulation of SOD1 (1.26 +- 0.07 fold change, p < 0.05), HSP70 (1.59 +- 0.28 fold change, p < 0.05), and HSP27 gene expression (1.49 +- 0.09 fold change, p < 0.05) after 3 hours from the first bout of exercise, followed by an increase in proteins' amount at 24 hours (SOD1, 1.80 +- 0.34 fold change; HSP70, 3.40 +- 0.58 fold change; and HSP27, 1.81 +- 0.20 fold change, p < 0.05) and return to basal levels after the 5 days of aerobic training. Indeed, the posttraining basal levels of oxidized molecules in plasma and PBMCs were statistically lower than the pretraining levels (carbonyl content, 0.50 +- 0.05 fold change, p < 0.01), paralleled by a lower expression of SOD2, Gpx1, and TrxR1, at mRNA (SOD2, 0.63 +- 0.06; GPx1, 0.69 +- 0.07; and TrxR1, 0.69 +- 0.12 fold change, p < 0.05) and protein (TrxR1, 0.49 +- 0.11 fold change, p < 0.05) levels. These results verified the existence of an early phase of redox adaptation to physical exercise already achievable after 5 days of moderate, regular aerobic training. More interestingly, this phenomenon was paralleled by the degree of NFkappaB activation in PBMCs and the decrease of plasmatic proinflammatory cytokines IL8, IL21, and IL22 in the posttraining period, suggesting an interconnected, short-term efficacy of aerobic exercise towards systemic oxidative stress and inflammation.
34853628	60	72	Inflammatory	Disease	MESH:D007249
34853628	294	306	inflammation	Disease	MESH:D007249
34853628	503	515	inflammatory	Disease	MESH:D007249
34853628	807	812	lipid	Chemical	MESH:D008055
34853628	844	866	superoxide dismutase-1	Gene	6647
34853628	868	872	SOD1	Gene	6647
34853628	902	906	SOD2	Gene	6648
34853628	909	931	glutathione peroxide 1	Gene	2876
34853628	933	937	GPx1	Gene	2876
34853628	940	963	thioredoxin reductase-1	Gene	7296
34853628	965	970	TrxR1	Gene	7296
34853628	977	985	catalase	Gene	847
34853628	987	990	CAT	Gene	847
34853628	1035	1056	heat shock protein-70	Gene	3308
34853628	1058	1063	HSP70	Gene	3308
34853628	1069	1090	heat shock protein-27	Gene	3316
34853628	1092	1097	HSP27	Gene	3316
34853628	1231	1239	NFkappaB	Gene	4790
34853628	1337	1349	inflammation	Disease	MESH:D007249
34853628	1404	1417	interleukin-6	Gene	3569
34853628	1419	1422	IL6	Gene	3569
34853628	1425	1438	interleukin-8	Gene	3576
34853628	1440	1443	IL8	Gene	3576
34853628	1446	1460	interleukin-10	Gene	3586
34853628	1462	1466	IL10	Gene	3586
34853628	1469	1484	interleukin-17E	Gene	64806
34853628	1486	1491	IL17E	Gene	64806
34853628	1494	1509	interleukin-17F	Gene	112744
34853628	1511	1516	IL17F	Gene	112744
34853628	1519	1533	interleukin-21	Gene	59067
34853628	1535	1539	IL21	Gene	59067
34853628	1542	1556	interleukin-22	Gene	50616
34853628	1558	1562	IL22	Gene	50616
34853628	1569	1583	interleukin-23	Gene	27178
34853628	1585	1589	IL23	Gene	51561
34853628	1705	1710	lipid	Chemical	MESH:D008055
34853628	1758	1762	SOD1	Gene	6647
34853628	1801	1806	HSP70	Gene	3308
34853628	1849	1854	HSP27	Gene	3316
34853628	2012	2016	SOD1	Gene	6647
34853628	2044	2049	HSP70	Gene	3308
34853628	2081	2086	HSP27	Gene	3316
34853628	2414	2418	SOD2	Gene	6648
34853628	2420	2424	Gpx1	Gene	2876
34853628	2430	2435	TrxR1	Gene	7296
34853628	2446	2450	SOD2	Gene	6648
34853628	2466	2470	GPx1	Gene	2876
34853628	2490	2495	TrxR1	Gene	7296
34853628	2546	2551	TrxR1	Gene	7296
34853628	2832	2840	NFkappaB	Gene	4790
34853628	2917	2920	IL8	Gene	3576
34853628	2922	2926	IL21	Gene	59067
34853628	2932	2936	IL22	Gene	50616
34853628	3073	3085	inflammation	Disease	MESH:D007249
34853628	Association	3316	3576
34853628	Association	3316	3586
34853628	Association	112744	3316
34853628	Association	3316	59067
34853628	Association	3316	64806
34853628	Association	3316	50616

